Nutra Pharma (NPHC) Stock Statistics & Valuation Metrics

Nutra Pharma has a market cap or net worth of $715.97K. The enterprise value is $10.70M.

Nutra Pharma has 7,159,727,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Nutra Pharma’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 20.70%.

The current PE Ratio of Nutra Pharma is ―. Nutra Pharma’s PEG ratio is 0.00.

In the last 12 months, Nutra Pharma had revenue of 385.31K and earned -2.05M in profits. Earnings per share was >-0.01.

In the last 12 months, operating cash flow was -1.09M and capital expenditures -2.00, giving a free cash flow of -1.09M billion.

Nutra Pharma pays an annual dividend of ―, resulting in a dividend yield of ―

Nutra Pharma upcoming earnings date is May 21, 2018, TBA (Confirmed).

Nutra Pharma as a current ratio of 0.03, with Debt / Equity ratio of -57.96%

In the past 12 months, Nutra Pharma has paid 0.00 in taxes.

Nutra Pharma EV to EBITDA ratio is -7.73, with an EV/FCF ratio of -8.84.

Nutra Pharma has $39.44K in cash and marketable securities with $10.01M in debt, giving a net cash position of -$9.97M billion.

Gross margin is 57.29%, with operating margin of -379.53%, and net profit margin of -531.37%.

The average price target for Nutra Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―